Literature DB >> 27422286

Endovascular Repair of Ruptured Infected Arteries as a Temporizing Measure Versus Destination Therapy.

Niti Shahi1, Jeontaik J Kwon1, Mariano Arosemena1, Dawn M Salvatore1, Paul J DiMuzio1, Babak Abai2.   

Abstract

OBJECTIVE: Mycotic rupture of the arteries is a rare but deadly disorder. Current management typically involves open surgical repair. However, endovascular repair is a potential treatment that can be used to delay open repair, especially in acutely unstable patients. A case report and review of the literature was conducted to determine whether endovascular therapy could be a destination therapy for patients with arterial rupture secondary to infection.
METHODS: We present the case of a 72-year-old man with a left common iliac artery aneurysm rupture secondary to Salmonella infection treated with endovascular therapy upon initial presentation. A literature review of PubMed yielded 29 patients with ruptured aortic and iliac infected aneurysms that were initially treated with endovascular repair.
RESULTS: Majority of the patients (76.7%, 23 of 30) were successfully treated with the endovascular treatment and did not require open revision. These patients were often placed on long-term antibiotics.
CONCLUSION: The literature review supports endovascular repair with a stent graft as a temporizing measure for infected ruptured arteries in an emergent setting and, in select cases, as a destination therapy.
© The Author(s) 2016.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27422286     DOI: 10.1177/1538574416655894

Source DB:  PubMed          Journal:  Vasc Endovascular Surg        ISSN: 1538-5744            Impact factor:   1.089


  2 in total

1.  Remote endarterectomy to remove infected Viabahn stent-graft.

Authors:  Christopher L Tarola; Morgan Young-Speirs; John W D Speirs; Carman M Iannicello
Journal:  J Vasc Surg Cases Innov Tech       Date:  2021-05-20

2.  Management of a Mycotic Aneurysm in a Patient with COVID-19: A Case Report.

Authors:  Muzammil H Syed; Mark Wheatcroft; Danny Marcuzzi; Hooman Hennessey; Mohammad Qadura
Journal:  Medicina (Kaunas)       Date:  2021-06-14       Impact factor: 2.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.